Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Mutations in CHCHD2 cause α-synuclein aggregation.

Ikeda A, Nishioka K, Meng H, Takanashi M, Inoshita T, Shiba-Fukushima K, Li Y, Yoshino H, Mori A, Okuzumi A, Yamaguchi A, Nonaka R, Izawa N, Ishikawa KI, Saiki H, Morita M, Hasegawa M, Hasegawa K, Elahi M, Funayama M, Okano H, Akamatsu W, Imai Y, Hattori N.

Hum Mol Genet. 2019 Oct 10. pii: ddz241. doi: 10.1093/hmg/ddz241. [Epub ahead of print]

PMID:
31600778
2.

Mutation analysis of LRP10 in Japanese patients with familial Parkinson's disease, progressive supranuclear palsy, and frontotemporal dementia.

Daida K, Nishioka K, Li Y, Yoshino H, Kikuchi A, Hasegawa T, Funayama M, Hattori N.

Neurobiol Aging. 2019 Sep 6. pii: S0197-4580(19)30309-4. doi: 10.1016/j.neurobiolaging.2019.08.030. [Epub ahead of print]

PMID:
31582232
3.

PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury.

Takahata K, Kimura Y, Sahara N, Koga S, Shimada H, Ichise M, Saito F, Moriguchi S, Kitamura S, Kubota M, Umeda S, Niwa F, Mizushima J, Morimoto Y, Funayama M, Tabuchi H, Bieniek KF, Kawamura K, Zhang MR, Dickson DW, Mimura M, Kato M, Suhara T, Higuchi M.

Brain. 2019 Oct 1;142(10):3265-3279. doi: 10.1093/brain/awz238.

PMID:
31504227
4.

Dementia trajectory for patients with logopenic variant primary progressive aphasia.

Funayama M, Nakagawa Y, Nakajima A, Takata T, Mimura Y, Mimura M.

Neurol Sci. 2019 Jul 22. doi: 10.1007/s10072-019-04013-z. [Epub ahead of print]

PMID:
31332581
5.

An ultra-rapid drug screening method for acetaminophen in blood serum based on probe electrospray ionization-tandem mass spectrometry.

Usui K, Kobayashi H, Fujita Y, Kubota E, Hanazawa T, Yoshizawa T, Kamijo Y, Funayama M.

J Food Drug Anal. 2019 Jul;27(3):786-792. doi: 10.1016/j.jfda.2019.02.001. Epub 2019 Feb 22.

6.

Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.

Lee JS, Kanai K, Suzuki M, Kim WS, Yoo HS, Fu Y, Kim DK, Jung BC, Choi M, Oh KW, Li Y, Nakatani M, Nakazato T, Sekimoto S, Funayama M, Yoshino H, Kubo SI, Nishioka K, Sakai R, Ueyama M, Mochizuki H, Lee HJ, Sardi SP, Halliday GM, Nagai Y, Lee PH, Hattori N, Lee SJ.

Brain. 2019 Sep 1;142(9):2845-2859. doi: 10.1093/brain/awz205.

PMID:
31312839
7.

A fast paraquat quantitation method in human serum using probe electrospray ionization-tandem mass spectrometry for emergency settings.

Usui K, Minami E, Fujita Y, Kobayashi H, Hanazawa T, Kamijo Y, Funayama M.

J Pharmacol Toxicol Methods. 2019 Jul 11;100:106610. doi: 10.1016/j.vascn.2019.106610. [Epub ahead of print]

PMID:
31302166
8.

Forced person-following: a new type of stimulus-bound behavior.

Funayama M, Takata T.

Neurocase. 2019 Jun - Aug;25(3-4):75-79. doi: 10.1080/13554794.2019.1638944. Epub 2019 Jul 3.

PMID:
31266394
9.

Prognostic factors for long-term improvement from stroke-related aphasia with adequate linguistic rehabilitation.

Nakagawa Y, Sano Y, Funayama M, Kato M.

Neurol Sci. 2019 Oct;40(10):2141-2146. doi: 10.1007/s10072-019-03956-7. Epub 2019 Jun 10.

10.

Resting-state hyperperfusion in the whole brain: A case of malignant catatonia that improved with electric convulsion therapy.

Kurose S, Koreki A, Funayama M, Takahashi E, Kaji M, Ogyu K, Takasu S, Koizumi T, Suzuki H, Onaya M, Mimura M.

Schizophr Res. 2019 Aug;210:287-288. doi: 10.1016/j.schres.2019.05.042. Epub 2019 Jun 6. No abstract available.

PMID:
31178364
11.
12.

Application of probe electrospray ionization-tandem mass spectrometry to ultra-rapid determination of glufosinate and glyphosate in human serum.

Usui K, Minami E, Fujita Y, Kubota E, Kobayashi H, Hanazawa T, Yoshizawa T, Kamijo Y, Funayama M.

J Pharm Biomed Anal. 2019 Sep 10;174:175-181. doi: 10.1016/j.jpba.2019.05.040. Epub 2019 May 29.

PMID:
31170631
13.

A metabolic profile of polyamines in parkinson disease: A promising biomarker.

Saiki S, Sasazawa Y, Fujimaki M, Kamagata K, Kaga N, Taka H, Li Y, Souma S, Hatano T, Imamichi Y, Furuya N, Mori A, Oji Y, Ueno SI, Nojiri S, Miura Y, Ueno T, Funayama M, Aoki S, Hattori N.

Ann Neurol. 2019 Aug;86(2):251-263. doi: 10.1002/ana.25516. Epub 2019 Jul 1.

14.

AST-120, an Adsorbent of Uremic Toxins, Improves the Pathophysiology of Heart Failure in Conscious Dogs.

Asanuma H, Chung H, Ito S, Min KD, Ihara M, Takahama H, Funayama M, Imazu M, Fukuda H, Ogai A, Asano Y, Minamino T, Takashima S, Morita T, Sugimachi M, Asakura M, Kitakaze M.

Cardiovasc Drugs Ther. 2019 Jun;33(3):277-286. doi: 10.1007/s10557-019-06875-z.

PMID:
30903544
15.

Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features.

Ikeda A, Shimada H, Nishioka K, Takanashi M, Hayashida A, Li Y, Yoshino H, Funayama M, Ueno Y, Hatano T, Sahara N, Suhara T, Higuchi M, Hattori N.

Mov Disord. 2019 Apr;34(4):568-574. doi: 10.1002/mds.27623. Epub 2019 Feb 17.

16.

Choking incidents among patients with schizophrenia may be associated with severity illness and higher-dose antipsychotics.

Funayama M, Takata T, Koreki A.

Gen Hosp Psychiatry. 2019 Jul - Aug;59:73-75. doi: 10.1016/j.genhosppsych.2018.09.001. Epub 2018 Sep 5. No abstract available.

PMID:
30745227
17.

Altered perception might be a symptom of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis.

Funayama M, Mizushima J, Takata T, Koreki A, Mimura M.

Neurocase. 2018 Oct - Dec;24(5-6):255-258. doi: 10.1080/13554794.2019.1573260. Epub 2019 Jan 25.

PMID:
30681026
18.

[Pica].

Funayama M.

Brain Nerve. 2018 Nov;70(11):1173-1180. doi: 10.11477/mf.1416201162. Japanese.

PMID:
30416110
19.

Remarkable behavioural signs and progressive non-fluent aphasia in a patient with adult-onset leucoencephalopathy with axonal spheroids and pigmented glia.

Funayama M, Sugihara M, Takata T, Mimura M, Ikeuchi T.

Psychogeriatrics. 2019 May;19(3):282-285. doi: 10.1111/psyg.12387. Epub 2018 Nov 4.

PMID:
30393946
20.

Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations.

Takanashi M, Funayama M, Matsuura E, Yoshino H, Li Y, Tsuyama S, Takashima H, Nishioka K, Hattori N.

Acta Neuropathol Commun. 2018 Oct 17;6(1):105. doi: 10.1186/s40478-018-0617-y.

21.

A quantitative morphological analysis of three-dimensional CT coxal bone images of contemporary Japanese using homologous models for sex and age estimation.

Biwasaka H, Aoki Y, Takahashi Y, Fukuta M, Usui A, Hosokai Y, Saito H, Funayama M, Fujita S, Takamiya M, Dewa K.

Leg Med (Tokyo). 2019 Feb;36:1-8. doi: 10.1016/j.legalmed.2018.09.017. Epub 2018 Oct 1.

PMID:
30300811
22.

Delusional misidentification of inanimate objects, persons, and places after a left orbitofrontal cortex injury.

Tanabe M, Funayama M, Narizuka Y, Nakajima A, Matsukawa I, Nakamura T.

Cortex. 2018 Dec;109:352-354. doi: 10.1016/j.cortex.2018.08.021. Epub 2018 Sep 18. No abstract available.

PMID:
30297316
23.

[Symptoms Specific to Schizophrenia].

Funayama M.

Brain Nerve. 2018 Sep;70(9):981-991. doi: 10.11477/mf.1416201118. Japanese.

PMID:
30177576
24.

Identification and functional characterization of novel mutations including frameshift mutation in exon 4 of CSF1R in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.

Miura T, Mezaki N, Konno T, Iwasaki A, Hara N, Miura M, Funayama M, Unai Y, Tashiro Y, Okita K, Kihara T, Ito N, Kanatsuka Y, Jones DT, Hara N, Ishiguro T, Tokutake T, Kasuga K, Nozaki H, Dickson DW, Onodera O, Wszolek ZK, Ikeuchi T.

J Neurol. 2018 Oct;265(10):2415-2424. doi: 10.1007/s00415-018-9017-2. Epub 2018 Aug 22.

25.

Conflict sign between an automatic and a controlled action and its process of improvement after damage to the left medial prefrontal cortex.

Hoshino E, Funayama M, Matsukawa I.

Neurol Sci. 2018 Nov;39(11):1991-1992. doi: 10.1007/s10072-018-3508-x. Epub 2018 Jul 22. No abstract available.

PMID:
30032333
26.

GCH1 mutations in dopa-responsive dystonia and Parkinson's disease.

Yoshino H, Nishioka K, Li Y, Oji Y, Oyama G, Hatano T, Machida Y, Shimo Y, Hayashida A, Ikeda A, Mogushi K, Shibagaki Y, Hosaka A, Iwanaga H, Fujitake J, Ohi T, Miyazaki D, Sekijima Y, Oki M, Kusaka H, Fujimoto KI, Ugawa Y, Funayama M, Hattori N.

J Neurol. 2018 Aug;265(8):1860-1870. doi: 10.1007/s00415-018-8930-8. Epub 2018 Jun 14.

PMID:
29948246
27.

Impairment in judgement of the moral emotion guilt following orbitofrontal cortex damage.

Funayama M, Koreki A, Muramatsu T, Mimura M, Kato M, Abe T.

J Neuropsychol. 2019 Sep;13(3):550-563. doi: 10.1111/jnp.12158. Epub 2018 Apr 19.

PMID:
29673084
28.

Direct detection of the psychoactive substance MT-45 in human tissue samples by probe electrospray ionization-tandem mass spectrometry.

Usui K, Murata T, Fujita Y, Kamijo Y, Hanazawa T, Yoshizawa T, Funayama M.

Drug Test Anal. 2018 Jun;10(6):1033-1038. doi: 10.1002/dta.2390. Epub 2018 May 3.

PMID:
29669397
29.

COQ2 variants in Parkinson's disease and multiple system atrophy.

Mikasa M, Kanai K, Li Y, Yoshino H, Mogushi K, Hayashida A, Ikeda A, Kawajiri S, Okuma Y, Kashihara K, Sato T, Kondo H, Funayama M, Nishioka K, Hattori N.

J Neural Transm (Vienna). 2018 Jun;125(6):937-944. doi: 10.1007/s00702-018-1885-1. Epub 2018 Apr 11.

PMID:
29644397
30.

Cotard's syndrome in anti-N-methyl-d-aspartate receptor encephalitis.

Funayama M, Takata T, Mimura M.

Psychiatry Clin Neurosci. 2018 Jun;72(6):455-456. doi: 10.1111/pcn.12658. Epub 2018 Apr 26. No abstract available.

31.

Pathological collecting behavior.

Funayama M, Takata T, Kato M, Mimura M.

Cortex. 2018 Jul;104:124-126. doi: 10.1016/j.cortex.2018.02.014. Epub 2018 Mar 3. No abstract available.

PMID:
29571960
32.

Catatonic Stupor in Schizophrenic Disorders and Subsequent Medical Complications and Mortality.

Funayama M, Takata T, Koreki A, Ogino S, Mimura M.

Psychosom Med. 2018 May;80(4):370-376. doi: 10.1097/PSY.0000000000000574.

33.

Genetic analysis of TMEM230 in Japanese patients with familial Parkinson's disease.

Conedera SA, Li Y, Funayama M, Yoshino H, Nishioka K, Hattori N.

Parkinsonism Relat Disord. 2018 Mar;48:107-108. doi: 10.1016/j.parkreldis.2017.12.020. Epub 2017 Dec 19.

PMID:
29305083
34.

Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease.

Fujimaki M, Saiki S, Li Y, Kaga N, Taka H, Hatano T, Ishikawa KI, Oji Y, Mori A, Okuzumi A, Koinuma T, Ueno SI, Imamichi Y, Ueno T, Miura Y, Funayama M, Hattori N.

Neurology. 2018 Jan 30;90(5):e404-e411. doi: 10.1212/WNL.0000000000004888. Epub 2018 Jan 3.

35.

Identification of 5-Fluoro ADB in Human Whole Blood in Four Death Cases.

Usui K, Fujita Y, Kamijo Y, Kokaji T, Funayama M.

J Anal Toxicol. 2018 Mar 1;42(2):e21-e25. doi: 10.1093/jat/bkx088.

PMID:
29186561
36.

iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer's Disease.

Kondo T, Imamura K, Funayama M, Tsukita K, Miyake M, Ohta A, Woltjen K, Nakagawa M, Asada T, Arai T, Kawakatsu S, Izumi Y, Kaji R, Iwata N, Inoue H.

Cell Rep. 2017 Nov 21;21(8):2304-2312. doi: 10.1016/j.celrep.2017.10.109.

37.

Induced pluripotent stem cells derived from a patient with familial idiopathic basal ganglia calcification (IBGC) caused by a mutation in SLC20A2 gene.

Sekine SI, Kondo T, Murakami N, Imamura K, Enami T, Shibukawa R, Tsukita K, Funayama M, Inden M, Kurita H, Hozumi I, Inoue H.

Stem Cell Res. 2017 Oct;24:40-43. doi: 10.1016/j.scr.2017.07.028. Epub 2017 Jul 29.

38.

Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutation.

Murakami N, Ishikawa T, Kondo T, Imamura K, Tsukita K, Enami T, Funayama M, Shibukawa R, Matsumoto S, Izumi Y, Ohta E, Obata F, Kaji R, Inoue H.

Stem Cell Res. 2017 Oct;24:36-39. doi: 10.1016/j.scr.2017.07.029. Epub 2017 Jul 29.

39.

Induced pluripotent stem cells derived from an autosomal dominant lateral temporal epilepsy (ADLTE) patient carrying S473L mutation in leucine-rich glioma inactivated 1 (LGI1).

Tan GW, Kondo T, Murakami N, Imamura K, Enami T, Tsukita K, Shibukawa R, Funayama M, Matsumoto R, Ikeda A, Takahashi R, Inoue H.

Stem Cell Res. 2017 Oct;24:12-15. doi: 10.1016/j.scr.2017.07.030. Epub 2017 Jul 29.

40.

Sudden death in a child caused by a giant cavernous hemangioma of the anterior mediastinum.

Igari Y, Takahashi S, Usui A, Kawasumi Y, Funayama M.

J Forensic Leg Med. 2017 Nov;52:93-97. doi: 10.1016/j.jflm.2017.08.008. Epub 2017 Aug 24.

PMID:
28886433
41.

Human Metapneumovirus M2-2 Protein Acts as a Negative Regulator of Alpha Interferon Production by Plasmacytoid Dendritic Cells.

Kitagawa Y, Sakai M, Funayama M, Itoh M, Gotoh B.

J Virol. 2017 Sep 27;91(20). pii: e00579-17. doi: 10.1128/JVI.00579-17. Print 2017 Oct 15.

42.

Postmortem Computed Tomographic Analysis of Death Caused by Oral Drug Intoxication.

Usui A, Kawasumi Y, Usui K, Ishizuka Y, Takahashi K, Funayama M, Saito H.

Tohoku J Exp Med. 2017 Jul;242(3):183-192. doi: 10.1620/tjem.242.183.

43.

Homozygous alpha-synuclein p.A53V in familial Parkinson's disease.

Yoshino H, Hirano M, Stoessl AJ, Imamichi Y, Ikeda A, Li Y, Funayama M, Yamada I, Nakamura Y, Sossi V, Farrer MJ, Nishioka K, Hattori N.

Neurobiol Aging. 2017 Sep;57:248.e7-248.e12. doi: 10.1016/j.neurobiolaging.2017.05.022. Epub 2017 Jun 27.

PMID:
28666710
44.

Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c.

Meng H, Yamashita C, Shiba-Fukushima K, Inoshita T, Funayama M, Sato S, Hatta T, Natsume T, Umitsu M, Takagi J, Imai Y, Hattori N.

Nat Commun. 2017 Jun 7;8:15500. doi: 10.1038/ncomms15500.

45.

Semantic memory deficits are associated with pica in individuals with acquired brain injury.

Funayama M, Muramatsu T, Koreki A, Kato M, Mimura M, Nakagawa Y.

Behav Brain Res. 2017 Jun 30;329:172-179. doi: 10.1016/j.bbr.2017.04.054. Epub 2017 Apr 29.

46.

Age estimation by ossification of thyroid cartilage of Japanese males using Bayesian analysis of postmortem CT images.

Aramaki T, Ikeda T, Usui A, Funayama M.

Leg Med (Tokyo). 2017 Mar;25:29-35. doi: 10.1016/j.legalmed.2016.12.001. Epub 2016 Dec 28.

PMID:
28457507
47.

A novel mutation of CHCHD2 p.R8H in a sporadic case of Parkinson's disease.

Ikeda A, Matsushima T, Daida K, Nakajima S, Conedera S, Li Y, Yoshino H, Oyama G, Funayama M, Nishioka K, Hattori N.

Parkinsonism Relat Disord. 2017 Jan;34:66-68. doi: 10.1016/j.parkreldis.2016.10.018. Epub 2016 Oct 24. No abstract available.

PMID:
28341223
48.

Mutation screening of PLA2G6 in Japanese patients with early onset dystonia-parkinsonism.

Yamashita C, Funayama M, Li Y, Yoshino H, Yamada H, Seino Y, Tomiyama H, Hattori N.

J Neural Transm (Vienna). 2017 Apr;124(4):431-435. doi: 10.1007/s00702-016-1658-7. Epub 2016 Dec 9.

PMID:
27942883
49.

Genotype-phenotype correlations of cysteine replacement in CADASIL.

Matsushima T, Conedera S, Tanaka R, Li Y, Yoshino H, Funayama M, Ikeda A, Hosaka Y, Okuzumi A, Shimada Y, Yamashiro K, Motoi Y, Nishioka K, Hattori N.

Neurobiol Aging. 2017 Feb;50:169.e7-169.e14. doi: 10.1016/j.neurobiolaging.2016.10.026. Epub 2016 Nov 2.

PMID:
27890607
50.

Lysosomal Storage of Subunit c of Mitochondrial ATP Synthase in Brain-Specific Atp13a2-Deficient Mice.

Sato S, Koike M, Funayama M, Ezaki J, Fukuda T, Ueno T, Uchiyama Y, Hattori N.

Am J Pathol. 2016 Dec;186(12):3074-3082. doi: 10.1016/j.ajpath.2016.08.006. Epub 2016 Oct 19.

PMID:
27770614

Supplemental Content

Loading ...
Support Center